Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Tocilizumab for treatment of mechanically ventilated patients with COVID-19

View ORCID ProfileEmily C Somers, View ORCID ProfileGregory A Eschenauer, View ORCID ProfileJonathan P Troost, View ORCID ProfileJonathan L Golob, Tejal N Gandhi, Lu Wang, View ORCID ProfileNina Zhou, Lindsay A Petty, View ORCID ProfileJi Hoon Baang, View ORCID ProfileNicholas O Dillman, View ORCID ProfileDavid Frame, Kevin S Gregg, View ORCID ProfileDan R Kaul, Jerod Nagel, Twisha S Patel, Shiwei Zhou, View ORCID ProfileAdam S Lauring, View ORCID ProfileDavid A Hanauer, Emily Martin, View ORCID ProfilePratima Sharma, View ORCID ProfileChristopher M Fung, View ORCID ProfileJason M Pogue
doi: https://doi.org/10.1101/2020.05.29.20117358
Emily C Somers
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
2University of Michigan, Department of Environmental Health Sciences, Ann Arbor, MI USA
3University of Michigan, Department of Obstetrics & Gynecology, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily C Somers
  • For correspondence: emsomers@umich.edu
Gregory A Eschenauer
4University of Michigan, Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gregory A Eschenauer
Jonathan P Troost
5University of Michigan, Michigan Institute for Clinical & Health Research, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan P Troost
Jonathan L Golob
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan L Golob
Tejal N Gandhi
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Wang
6University of Michigan, Department of Biostatistics, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nina Zhou
6University of Michigan, Department of Biostatistics, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nina Zhou
Lindsay A Petty
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ji Hoon Baang
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ji Hoon Baang
Nicholas O Dillman
7University of Michigan, Department of Pharmacy, Michigan Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas O Dillman
David Frame
4University of Michigan, Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Frame
Kevin S Gregg
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan R Kaul
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dan R Kaul
Jerod Nagel
7University of Michigan, Department of Pharmacy, Michigan Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Twisha S Patel
7University of Michigan, Department of Pharmacy, Michigan Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiwei Zhou
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam S Lauring
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam S Lauring
David A Hanauer
8University of Michigan, Department of Learning Health Sciences, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David A Hanauer
Emily Martin
9University of Michigan, Department of Epidemiology, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pratima Sharma
1University of Michigan, Department of Internal Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pratima Sharma
Christopher M Fung
10University of Michigan, Department of Emergency Medicine, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher M Fung
Jason M Pogue
4University of Michigan, Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, MI USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jason M Pogue
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Severe COVID-19 can manifest in rapid decompensation and respiratory failure with elevated inflammatory markers. This presentation is consistent with cytokine release syndrome in chimeric antigen receptor T cell therapy, for which IL-6 blockade is approved treatment.

Methods We assessed effectiveness and safety of IL-6 blockade with tocilizumab in a single-center cohort of patients with COVID-19 requiring mechanical ventilation. The primary endpoint was survival probability post-intubation; secondary analyses included an ordinal illness severity scale integrating superinfections. Outcomes in patients who received tocilizumab compared to tocilizumab-untreated controls were evaluated using multivariable Cox regression with propensity score inverse probability weighting (IPTW).

Findings 154 patients were included, of whom 78 received tocilizumab and 76 did not. Median follow-up was 47 days (range 28-67). Baseline characteristics were similar between groups, although tocilizumab-treated patients were younger (mean 55 vs. 60 years), less likely to have chronic pulmonary disease (10% vs. 28%), and had lower D-dimer values at time of intubation (median 2.4 vs. 6.5 mg/dL). In IPTW-adjusted models, tocilizumab was associated with a 45% reduction in hazard of death [hazard ratio 0.55 (95% CI 0.33, 0.90)] and improved status on the ordinal outcome scale [odds ratio per 1-level increase: 0.59 (0.36, 0.95)]. Though tocilizumab was associated with an increased proportion of patients with superinfections (54% vs. 26%; p<0.001), there was no difference in 28-day case fatality rate among tocilizumab-treated patients with versus without superinfection [22% vs. 15%; p=0.42].

Interpretation In this cohort of mechanically ventilated COVID-19 patients, tocilizumab was associated with a decreased likelihood of death despite higher superinfection occurrence. Randomized controlled trials are urgently needed to confirm these findings.

Question Can therapy with the IL-6 receptor antagonist tocilizumab improve outcomes in patients with severe COVID-19 illness requiring mechanical ventilation?

Findings In this observational, controlled study of 154 patients, receipt of tocilizumab was associated with a 45% reduction in the hazard of death, despite twice the frequency of superinfection (54% vs 26%), both of which were statistically significant findings.

Meaning Tocilizumab therapy may improve survival in patients with COVID-19 illness requiring mechanical ventilation. These results can inform clinical practice pending the results of randomized clinical trials.

Competing Interest Statement

Disclosures: Dr.Troost reports stock in Proctor & Gamble and General Electric; Dr. Lauring reports being a paid consultant on antivirals for Sanofi and a paid member of a clinical trial steering committee for Baloxavir for Roche; Dr. Martin reports being a paid consultant for Pfizer on RSV and receipt of research funding from Roche.

Funding Statement

This work was supported by the National Institutes of Health (NIH/NCATS UL1TR002240; NIH/NHLBI 1K12HL133304 to CMF); the Centers for Disease Control and Prevention (CDC U01IP000974); and an ASTCT New Investigator Award (to JLG). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the NIH, CDC or the Department of Health and Human Services.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval was obtained by the Institutional Review Board of the University of Michigan.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data contain PHI and only accessible to IRB-approved investigators

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, Jonathan L Golob, Tejal N Gandhi, Lu Wang, Nina Zhou, Lindsay A Petty, Ji Hoon Baang, Nicholas O Dillman, David Frame, Kevin S Gregg, Dan R Kaul, Jerod Nagel, Twisha S Patel, Shiwei Zhou, Adam S Lauring, David A Hanauer, Emily Martin, Pratima Sharma, Christopher M Fung, Jason M Pogue
medRxiv 2020.05.29.20117358; doi: https://doi.org/10.1101/2020.05.29.20117358
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, Jonathan L Golob, Tejal N Gandhi, Lu Wang, Nina Zhou, Lindsay A Petty, Ji Hoon Baang, Nicholas O Dillman, David Frame, Kevin S Gregg, Dan R Kaul, Jerod Nagel, Twisha S Patel, Shiwei Zhou, Adam S Lauring, David A Hanauer, Emily Martin, Pratima Sharma, Christopher M Fung, Jason M Pogue
medRxiv 2020.05.29.20117358; doi: https://doi.org/10.1101/2020.05.29.20117358

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (413)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8550)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1744)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1237)
  • Health Policy (619)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10281)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1670)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (926)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (247)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1764)
  • Public and Global Health (3832)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (74)